Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
Phase 3
Completed
- Conditions
- Pancreatic Neoplasms
- Interventions
- First Posted Date
- 2004-05-21
- Last Posted Date
- 2011-05-19
- Target Recruit Count
- 688
- Registration Number
- NCT00005648
Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
Phase 3
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2011-05-20
- Target Recruit Count
- 83
- Registration Number
- NCT00082602
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
Phase 3
Terminated
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2014-10-09
- Target Recruit Count
- 62
- Registration Number
- NCT00082095
Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 630
- Registration Number
- NCT00078039
Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-02-16
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 12
- Registration Number
- NCT00077714
A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-02-16
- Last Posted Date
- 2011-05-24
- Target Recruit Count
- 107
- Registration Number
- NCT00077727
Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
Phase 3
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2004-01-16
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 13
- Registration Number
- NCT00076115
Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia
Phase 2
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2003-12-15
- Last Posted Date
- 2011-05-24
- Target Recruit Count
- 250
- Registration Number
- NCT00074477
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2003-11-21
- Last Posted Date
- 2010-04-27
- Target Recruit Count
- 88
- Registration Number
- NCT00073320
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2003-11-19
- Last Posted Date
- 2009-08-28
- Target Recruit Count
- 488
- Registration Number
- NCT00073203
- Locations
- 🇺🇸
JJ PRD Research Center, Titusville, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath